| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.1M | +71.2% |
| Cost of Revenue | $1.3M | +1849.2% |
| R&D Expense | $143.8M | -33.1% |
| SG&A Expense | $52.7M | -29.4% |
| Operating Income | -$184.3M | +34.8% |
| Pre-tax Income | -$237.1M | +22.6% |
| Income Tax | $2.4M | +26.4% |
| Net Income | -$239.6M | +22.3% |
| EPS (Basic) | -$4.92 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $158.9M | -34.2% |
| Inventory | $12.0M | +0.0% |
| Current Assets | $390.3M | -40.1% |
| Total Assets | $556.5M | -33.1% |
| Current Liabilities | $40.1M | -45.6% |
| Long-term Debt | $66.0M | -55.3% |
| Total Liabilities | $563.3M | -9.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$182.7M | -25.2% |
| Capital Expenditures | $3.4M | -52.9% |
| Investing Cash Flow | $163.0M | +179.2% |
| Financing Cash Flow | -$59.5M | -116.4% |
| Free Cash Flow | -$186.1M | -21.6% |
| +24.0% |
| EPS (Diluted) | -$4.92 | +24.0% |
| Stockholders' Equity |
| -$6.8M |
| -103.3% |